XML 51 R37.htm IDEA: XBRL DOCUMENT v3.23.3

Investments in and Advances to Joint Ventures (Tables)

9 Months Ended

Sep. 30, 2023

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

		September 30, 2023				December 31, 2022
Current assets		$	418,854			$	289,837
Noncurrent assets			11,637				9,961
Total assets			430,491				299,798
Current liabilities			278,168				194,701
Noncurrent liabilities			3,504				3,763
Total liabilities			281,672				198,464
Total joint venture equity		$	148,819			$	101,334

		Three Months Ended								Nine Months Ended
		September 30, 2023				September 30, 2022				September 30, 2023				September 30, 2022
Revenue		$	185,602			$	130,344			$	514,339			$	333,967
Costs			160,423				101,882				445,829				289,485
Net income		$	25,179			$	28,462			$	68,510			$	44,482
Net income attributable to noncontrolling interests		$	12,364			$	14,024			$	33,617			$	21,685

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

		September 30, 2023				December 31, 2022
Current assets		$	1,513,825			$	1,610,246
Noncurrent assets			481,708				491,658
Total assets			1,995,533				2,101,904
Current liabilities			960,276				1,255,297
Noncurrent liabilities			503,705				468,056
Total liabilities			1,463,981				1,723,353
Total joint venture equity		$	531,552			$	378,551
Investments in and advances to unconsolidated joint ventures		$	164,858			$	107,425

		Three Months Ended								Nine Months Ended
		September 30, 2023				September 30, 2022				September 30, 2023				September 30, 2022
Revenue		$	634,937			$	782,880			$	1,514,561			$	1,762,420
Costs			581,041				774,030				1,474,991				1,711,555
Net income		$	53,896			$	8,850			$	39,570			$	50,865
Equity in (losses) earnings of unconsolidated joint ventures		$	10,262			$	(974	)		$	4,497			$	10,237

X

- Definition

Schedule of financial information of consolidated joint ventures.

+ References

No definition available.

+ Details

Name:	psn_ScheduleOfFinancialInformationOfConsolidatedJointVenturesTableTextBlock
Namespace Prefix:	psn_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

+ Details

Name:	us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration